LPAR3 and COL8A1, as matrix stiffness-related biomarkers, promote nasopharyngeal carcinoma metastasis by triggering EMT and angiogenesis.

Cellular signalling [Cell Signal] 2025 Jul; Vol. 131, pp. 111712. Date of Electronic Publication: 2025 Mar 04.

Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Matrix stiffness affects the progression of nasopharyngeal carcinoma, but the underlying mechanism is still unknown. Here, we demonstrated that nasopharyngeal carcinoma tissues with distant metastasis contain large collagen deposits and strong matrix stiffness. First, we performed RNA-seq analysis of nasopharyngeal carcinoma cells cultured on polyacrylamide hydrogel systems and found that LPAR3 and COL8A1 are potential matrix stiffness markers. Based on in vivo and in vitro experiments, matrix stiffness mainly affected tumor metastasis rather than proliferation. Subsequently, we found that matrix stiffness triggers the formation of epithelial-mesenchymal transition by increasing the expression of LPAR3 in nasopharyngeal carcinoma, which is related to metastasis. In addition, matrix stiffness promotes the expression of COL8A1 secreted by nasopharyngeal carcinoma and is related to tumor angiogenesis. Simultaneous inhibition of LPAR3 and COL8A1 genes significantly reduced nasopharyngeal carcinoma invasion and metastasis. Based on the investigation, we confirmed that matrix stiffness governs the progression of nasopharyngeal carcinoma and that LPAR3 and COL8A1, as matrix stiffness related biomarkers, promote nasopharyngeal carcinoma metastasis by inducing epithelial-mesenchymal transition and angiogenesis. Overall, the in-depth exploration of matrix stiffness may provide a strategy for clinical treatment intervention and provide promising targets for clinical nasopharyngeal carcinoma treatment.
(Copyright © 2025 The Authors. Published by Elsevier Inc. All rights reserved.)

English

Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 8904683 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-3913 (Electronic) Linking ISSN: 08986568 NLM ISO Abbreviation: Cell Signal Subsets: MEDLINE

Epithelial-Mesenchymal Transition* , Nasopharyngeal Carcinoma*/pathology , Nasopharyngeal Carcinoma*/metabolism , Nasopharyngeal Carcinoma*/genetics , Neovascularization, Pathologic*/metabolism , Neovascularization, Pathologic*/pathology , Neovascularization, Pathologic*/genetics , Receptors, Lysophosphatidic Acid*/metabolism , Receptors, Lysophosphatidic Acid*/genetics , Nasopharyngeal Neoplasms*/pathology , Nasopharyngeal Neoplasms*/metabolism , Nasopharyngeal Neoplasms*/genetics , Biomarkers, Tumor*/metabolism , Biomarkers, Tumor*/genetics, Humans ; Cell Line, Tumor ; Animals ; Extracellular Matrix/metabolism ; Neoplasm Metastasis ; Mice, Nude ; Mice ; Gene Expression Regulation, Neoplastic ; Mice, Inbred BALB C ; Cell Proliferation ; Female ; Male ; Angiogenesis

20250414